Skip to main content
Vyome Holdings, Inc logo

Vyome Holdings, Inc — Investor Relations & Filings

Ticker · HIND ISIN · US67424L2097 US Manufacturing
Open in API
Filings indexed 590 across all filing types
Latest filing 2025-05-28 Regulatory Filings
Country US United States of America
Listing US HIND

About Vyome Holdings, Inc

https://www.reshapelifesciences.com/oba…

Vyome Holdings, Inc. is a clinical-stage biotechnology company focused on developing a portfolio of assets for immuno-inflammatory and potential orphan diseases. The company utilizes an artificial intelligence (AI)-driven platform to accelerate its research and development pipeline. Its operations are structured to leverage innovation and R&D capabilities across both the United States and India.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by ReShape Lifesciences Inc. It reports on a merger agreement and provides financial statements and management discussion and analysis (MD&A) for Vyome Therapeutics and the company for specific periods. The document includes references to quarterly and annual financial data, pro forma combined financial statements, and is filed to incorporate this information by reference into a shelf registration statement. The Form 8-K is a current report used to announce significant events, including mergers and acquisitions, and related financial disclosures. This filing is not the full annual report (10-K) or quarterly report (10-Q), nor is it a proxy, earnings release, or other specific report type. It is a regulatory filing reporting a material event and attaching financial exhibits related to the merger. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-05-28 English
10-Q Filing
Interim / Quarterly Report Q1 2025
2025-05-20 English
S-4/A Filing
M&A Activity Classification · 95% confidence The document is an Amendment No. 5 to a Form S-4 Registration Statement filed with the SEC by ReShape Lifesciences Inc. Form S-4 is used for registration of securities in connection with business combinations such as mergers and acquisitions. The text includes detailed legal and indemnification provisions related to the merger, references to exhibits, and undertakings related to the registration statement. There is no financial statement data or earnings information, nor is this a proxy statement or voting results announcement. The document is clearly related to merger and acquisition activity and is a regulatory filing for securities registration in connection with a merger. Therefore, the most appropriate classification is M&A Activity (Code: TAR). The document length and content confirm it is not a brief announcement or a certification, so it is not RNS or RPA. Confidence is high due to the explicit mention of Form S-4 and merger-related content.
2025-05-14 English
SCHEDULE 13G Filing
Major Shareholding Notification
2025-05-14 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2025-05-12 English
S-4/A Filing
Merger & Acquisition Classification · 100% confidence The document is a Form S-4 Registration Statement filed with the SEC, which is used for securities registration in connection with mergers and acquisitions. It includes detailed information about a merger proposal between ReShape Lifesciences Inc. and Vyome Therapeutics Inc., including the merger agreement, share exchange ratio, asset purchase agreement, promissory note, and details about the special meeting for shareholder approval. The document is not a simple announcement but a comprehensive filing related to a merger transaction. This fits the definition of a Merger & Acquisition (MA) filing, which includes merger communications and related registration statements. The document is lengthy (15,000 characters) and contains substantive merger-related content, not just an announcement or proxy solicitation alone. Therefore, the appropriate classification is Merger & Acquisition (MA).
2025-05-09 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.